Lisinopril and Hydrochlorothiazide
- Product NDC
- 50436-8000
- 11-digit product format
- 504368000
- Labeler code
- 50436
- Product ID
- 50436-8000_2eeaa323-5e45-4e06-aa0e-b6af68e0bf2c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2006-04-10
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record